CSF1 and neoplasm: For example, downregulation of CCL2 reduces tumor growth in prostate cancers [61] and inhibits cancer stem cell properties in breast cancers [62], and targeting CSF-1 can reduce TAMs and enhance the ratio of CD8+ to CD4+ T-cells [63].